動物バイオテクノロジー市場規模、シェア、競争環境およびトレンド分析レポート:エンドユーザー別(医薬品、農業、研究開発、食品生産、バイオテクノロジー)、技術別(遺伝子編集、ゲノミクス、プロテオミクス、バイオインフォマティクス、幹細胞技術)、用途別(遺伝子工学、分子診断、動物健康、生殖バイオテクノロジー、トランスジェニック動物): 2026年から2035年までの機会分析および業界予測

レポートID : ROJP02261002  |  最終更新 : 2026年02月  |  フォーマット :  :   : 

Table of Content

Chapter 1. Executive Summary: Animal Biotechnology Market
Chapter 2. Research Methodology & Research Framework

2.1. Research Objective
2.2. End Use Overview
2.3. Market Segmentation
2.4. Qualitative Research
2.4.1. Primary & Secondary Sources
2.5. Quantitative Research
2.5.1. Primary & Secondary Sources
2.6. Breakdown of Primary Research Respondents, By Region
2.7. Assumption for Study
2.8. Market Size Estimation
2.9. Data Triangulation

Chapter 3. Animal Biotechnology Market Overview

3.1. Industry Value Chain Analysis
3.1.1. Technology Provider
3.1.2. Manufacturer
3.1.3. Distributor
3.1.4. Technologys
3.2. Industry Outlook
3.2.1. Overview of Animal Biotechnology Market
3.2.2. EXIM Data
3.3. PESTLE Analysis
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Dynamics and Trends
3.5.1. Growth Drivers
3.5.1.1. Rising need to develop genetically modified therapeutic proteins
3.5.2. Restraints
3.5.2.1. High development costs pose a challenge for small players.
3.5.3. Opportunity
3.5.3.1 Growing awareness regarding animal health and welfare
3.5.4. Key Trend
3.6. Market Growth and Outlook
3.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2025 – 2035
3.6.2. Price Trend Analysis

Chapter 4. Competition Dashboard

4.1. Market Concentration Rate
4.2. Company Market Share Analysis (Value %), 2025
4.3. Competitor Mapping & Benchmarking

Chapter 5. Animal Biotechnology Market Analysis

5.1. Key Insights
5.2. Market Size and Forecast, 2026-2035 (US$ Mn)
5.2.1. By End Use
5.2.1.1. Pharmaceuticals
5.2.1.2. Agriculture
5.2.1.3 Research and Development
5.2.1.4. Food Production
5.2.1.5. Biotechnology
5.2.2. By Technology
5.2.2.1. Gene Editing
5.2.2.2. Genomics
5.2.2.3. Proteomics
5.2.2.4. Bioinformatics
5.2.2.5. Stem Cell Technology
5.2.3. By Application
5.2.3.1. Genetic Engineering
5.2.3.2. Molecular Diagnostics
5.2.3.3. Animal Health
5.2.3.4. Reproductive Biotechnology
5.2.3.5. Transgenic Animals
5.2.4. By Region
5.2.4.1. North America
5.2.4.1.1. The U.S.
5.2.4.1.2. Canada
5.2.4.1.3. Mexico
5.2.4.2. Europe
5.2.4.2.1. Western Europe
5.2.4.2.1.1. UK
5.2.4.2.1.2. Germany
5.2.4.2.1.3. France
5.2.4.2.1.4. Italy
5.2.4.2.1.5. Spain
5.2.4.2.1.6. Rest of Western Europe
5.2.4.2.2. Eastern Europe
5.2.4.2.2.1. Poland
5.2.4.2.2.2. Russia
5.2.4.2.2.3. Rest of Eastern Europe
5.2.4.3. Asia Pacific
5.2.4.3.1. China
5.2.4.3.2. India
5.2.4.3.3. Japan
5.2.4.3.4. South Korea
5.2.4.3.5. Australia & New Zealand
5.2.4.3.6. ASEAN
5.2.4.3.7. Rest of Asia Pacific
5.2.4.4. Middle East & Africa
5.2.4.4.1. UAE
5.2.4.4.2. Saudi Arabia
5.2.4.4.3. South Africa
5.2.4.4.4. Rest of MEA
5.2.4.5. South America
5.2.4.5.1. Argentina
5.2.4.5.2. Brazil
5.2.4.5.3. Rest of South America

Chapter 6. North America Animal Biotechnology Market Analysis

6.1. Market Dynamics and Trends
6.1.1. Growth Drivers
6.1.2. Restraints
6.1.3. Opportunity
6.1.4. Key Trends
6.2. Market Size and Forecast, 2026-2035 (US$ Mn)
6.2.1. By End Use
6.2.2. By Technology
6.2.3. By Application
6.2.4. By Region

Chapter 7. Europe Animal Biotechnology Market Analysis

7.1. Market Dynamics and Trends
7.1.1. Growth Drivers
7.1.2. Restraints
7.1.3. Opportunity
7.1.4. Key Trends
7.2. Market Size and Forecast, 2026-2035 (US$ Mn)
7.2.1. By End Use
7.2.2. By Technology
7.2.3. By Application
7.2.4. By Region

Chapter 8. Asia Pacific Animal Biotechnology Market Analysis

8.1. Market Dynamics and Trends
8.1.1. Growth Drivers
8.1.2. Restraints
8.1.3. Opportunity
8.1.4. Key Trends
8.2. Market Size and Forecast, 2026-2035 (US$ Mn)
8.2.1. By End Use
8.2.2. By Technology
8.2.3. By Application
8.2.4. By Region

Chapter 9. Middle East & Africa Animal Biotechnology Market Analysis

9.1. Market Dynamics and Trends
9.1.1. Growth Drivers
9.1.2. Restraints
9.1.3. Opportunity
9.1.4. Key Trends
9.2. Market Size and Forecast, 2026-2035 (US$ Mn)
9.2.1. By End Use
9.2.2. By Technology
9.2.3. By Application
9.2.4. By Region

Chapter 10. South America Animal Biotechnology Market Analysis

10.1. Market Dynamics and Trends
10.1.1. Growth Drivers
10.1.2. Restraints
10.1.3. Opportunity
10.1.4. Key Trends
10.2. Market Size and Forecast, 2026-2035 (US$ Mn)
10.2.1. By End Use
10.2.2. By Technology
10.2.3. By Application
10.2.4. By Region

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key End Use landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

11.1. Zoetis
11.2. Merck Animal Health
11.3. Boehringer Ingelheim
11.4. Elanco Animal Health
11.5. Ceva Santé Animale
11.6. Virbac
11.7. Merial
11.8. Heska Corporation
11.9. Neogen Corporation
11.10. Others

Chapter 12. Annexure

12.1. List of Secondary Sources
12.2. Macro Economic Outlook/Indicators

Booklet
  • 最終更新 :
    2026年02月
  • 予想年 :
    2026年~2035年
  • 納期 :
    即日から翌営業日

レポート言語: 英語、日本語

   無料サンプルを入手する arrow icn

この無料サンプルには、トレンド分析から推定・予測まで、さまざまなデータが含まれています。

お問い合わせ

マルチレポートプラン
必要なレポート数に応じて、カスタマイズされたプランをご提供します.
2024年の予算を無駄にしないでください!
残りの予算を活用して、将来の成功を確かなものにしましょう。

データに基づく貴重な洞察で、2025年を力強くスタートさせてください。